Aldevron, a global supplier of DNA, RNA, and protein, and Integrated DNA Technologies (IDT), a genomics solutions provider, have announced the successful production of the first personalised CRISPR gene editing drug for a paediatric patient with urea cycle disorder. Developed in partnership
TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, has entered into a non-exclusive License and Supply Agreement with Aldevron, a global CDMO specialising in the production of plasmid DNA, RNA, and proteins. This partnership aims to expand access to TriLink’s CleanCap
Aldevron, a global manufacturer of DNA, RNA, and proteins, has announced a strategic partnership with Acuitas Therapeutics, a private biotechnology company that specialises in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNPs). The collaboration
